FDA Investigator Gary L Zaharek

Gary L Zaharek has conducted inspections on 217 sites in 2 countries as of 18 Mar 2010. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
217
Last Inspection Date:
18 Mar 2010
Investigator Role:
FDA Investigator
Redica ID:
100008786
Countries of Inspections:
United States of America, Canada
FDA Investigators that have inspected at least one site in common with Gary L Zaharek:
Abraham M Maekele, Alla Dubrovsky, Althea A Williams, Amogh Pathi, Anderson, Andrea P Scott, Anthony E Keller, RPh, Barbara J Moynier, Brenda L Reihing, Brittany D Mccracken, Calvin K Cook, Catherine J Laufmann, Christine M Parmentier, Christopher S Genther, Daniel C Geffin, Deborah A Nebenzahl, Dennis G Kawabata, Dennis R Butcher, Dolores Harper, Don A Leeseberg, Dustin R Abaonza, Emir Galevi, Eric J Heinze, Eric M Padgett, Eric W Anderson, Finn A Slizza, Francis J Eng, Frank P Bianco, James A Lane, James D Hildreth, James E Frye, James W Whitney, Jeff A Gard, Jeffrey W Shrifter, DPM, Jinkee Mvila Binayug, Jocelyn E Massey, Jocelyn T Ramos, John A Hall, John A Sciacchitano, John E Emmert, Jolene S Hedgecock, Joseph A Seitz, III, Juan A Morales, Jude C Dikes, Karen D Phung, Kellie L Thommes, RN, Kham Phommachanh, Kimberly L Anderson, Kimberly L Pruszko, Kimberly Lewandowski Walker, Kingj, Laverne Kimble, Lawton W Lum, Leo J Lagrotte, Linda Linh N Adams, Linda S Shook, Lori J Silverstein, Lorna F Jones, LT Mark A Chen, MPH, Lydia S Chan, Maida Henesian (NMI), Mark E Chan, Marlo Ianm Alintanahin, Mary R Hole, Matthew A Walburger, Miaja Umaedi, Nancy A Saxenian Emmons, Paul M Kawamoto, Philip E Ake, Phillip M Pontikos, Quynh H Strandberg, Rebecca L Stephany, Rosanna M Goodrich, Ruark Lanham, Samuel K Gibbons, Jr, Scott A Nabe, Seema S Singh, Selene T Torres, Sergio Chavez (NMI), Sherri N Rohlf, MD, Stanley B Eugene, BS, BME, Stuart W Russell, Suzie L Kent, Tamara S Rosbury, Timothy C Grome, Trang N Cox, Vanessa R Muller, Xiaojun Yan, Yvette Mlacour Davis

Gary L Zaharek's Documents

Publish Date Document Type Title
April, 2000 FDA 483 SDL, Inc - Form 483, 2000-04-14
November, 2002 FDA 483 Lumenis Inc. - Form 483, 2002-11-25
April, 2005 EIR HDC Corporation - EIR, 2005-04-13
November, 2003 FDA 483 New Wave Research Division of esi - Form 483, 2003-11-19
December, 2001 EIR Abbott Laboratories - EIR, 2001-12-17
October, 2003 FDA 483 Laser Reference - Form 483, 2003-10-29
August, 2003 FDA 483 Sunrise Telecom Inc - Form 483, 2003-08-27
June, 2001 EIR MML Diagnostics Packaging, Inc - EIR, 2001-06-12
December, 2001 FDA 483 Abbott Laboratories - Form 483, 2001-12-17
November, 2003 EIR New Wave Research Division of esi - EIR, 2003-11-19
July, 2007 EIR VISX INCORPORATED, A SUBSIDIARY OF AMO INC - EIR, 2007-07-31
July, 2007 FDA 483 VISX INCORPORATED, A SUBSIDIARY OF AMO INC - Form 483, 2007-07-31
September, 2009 FDA 483 Cardiva Medical, Inc. - Form 483, 2009-09-03
September, 2009 FDA 483 Siemens Industry Inc - Form 483, 2009-09-15
April, 2001 FDA 483 Semler Technologies Inc - Form 483, 2001-04-24
December, 2005 EIR Nidek, Inc. - EIR, 2005-12-15
October, 2003 EIR Laser Reference - EIR, 2003-10-29
August, 2003 FDA 483 Onetta, Inc. - Form 483, 2003-08-20
December, 2002 FDA 483 Molecular Devices Corp. - Form 483, 2002-12-04
April, 2001 FDA 483 Response Semler Technologies Inc - Form 483R, 2001-05-21
April, 2001 EIR Semler Technologies Inc - EIR, 2001-04-24
August, 2003 EIR Sunrise Telecom Inc - EIR, 2003-08-27
May, 2007 FDA 483 Illumina, Inc. - Form 483, 2007-05-18
April, 2005 FDA 483 HDC Corporation - Form 483, 2005-04-13
June, 2001 FDA 483 Response MML Diagnostics Packaging, Inc - Form 483R, 2001-07-11
June, 2001 FDA 483 MML Diagnostics Packaging, Inc - Form 483, 2001-06-12

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more